New York City, NY, 24 February, 2020/ 24 Market Reports: It is estimated for the global single-cell analysis market to grow from USD 2.4 billion in 2019 and reach that of USD 5.3 billion by 2025, witnessing the growth at a CAGR of 17.4% during the forecast period of 2019 to 2025. The technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine and the increasing incidence and prevalence of chronic and infectious diseases are the factors that are driving the growth of the market during the forecast period. The high cost of single-cell analysis products is expected to hinder the growth of the single-cell analysis market during the forecast period.
Consumables segment to hold the major share in the market during the forecast period
Consumables (beads, microplates, reagents, assay kits, and other consumables) and instruments (flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays, and other instruments) are the segmentation for the market based on product. The consumables segment accounted for the major share in the market in the year 2018 and the trend is estimated to continue throughout the forecast period. The frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are the factors that are driving the growth of the market during the forecast period.
Human cells segment, by type, to account for the largest share in the single-cell analysis market
Human, animal and microbial cells are the segmentation for the single-cell analysis market based on cell type. In the year 2018, the human cells accounted for the largest share in the market and the trend is estimated to continue throughout the forecast period. The high utilization of human cells in research laboratories and academic institutes is driving the growth of the market during the forecast period.
Research applications segment to lead the market during the forecast period
Research (cancer, immunology, neurology, stem cell, and other research applications) and medical applications (noninvasive prenatal diagnosis, in vitro fertilization, and circulating tumour cell detection) are the segmentation for the market based on applications. The research applications segment led the market in 2018 and is estimated to continue throughout the forecast period. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are driving the growth of the market during the forecast period.
NGS segment, by technology, to grow at the highest rate in the market during the forecast period
By technique, flow cytometry, NGS, PCR, microscopy, mass spectrometry and other techniques are the segmentation for the global market. During the forecast period, it is estimated for the NGS segment to grow at the highest rate in the market. The increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases is driving the growth for the NGS segment in the market during the forecast period.
Academic and research laboratories to occupy the largest share in the global market
Academic and research laboratories, biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and cell banks and IVF centres are the segmentation for the market based on the end-user. The academic and research laboratories segment to hold the largest share in the market during the forecast period. The market is driven by factors such as growth in funding for life science research and the increasing number of medical colleges and universities during the forecast period.
Asia Pacific region to lead the market throughout the forecast period
North America, Europe, Asia Pacific, Latin America and the Middle East & Africa are the segmentation for the market based on geography. It is estimated for the Asia Pacific region to lead the market during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs are the factors that are driving the growth of the market during the forecast period.
The following are the major objectives of the study:
- To define, describe, and forecast the global single-cell analysis market on the basis of product, application and region.
- To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, and opportunities).
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.
- To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players.
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
- To strategically profile the key market players and comprehensively analyze their market shares and core competencies.
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, agreements, and collaborations in the global single-cell analysis market.
Critical Questions which the report answers:
- What are the major vendor/manufacturers in the market? What is their growth potential during next decade?
- What are the key revenue generating pockets for global single-cell analysis market and their future potential during next decade?
- How competitive landscape is evolving in global single-cell analysis market?
Download a Full Report on "Single Cell Analysis Market", Click Here
